Rusakiewicz, S., Perier, A., Semeraro, M., Pitt, J. M., Pogge von Strandmann, E., Reiners, K. S., . . . Zitvogel, L. (2016). NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. Oncoimmunology.
Citação norma ChicagoRusakiewicz, Sylvie, et al. "NKp30 Isoforms and NKp30 Ligands Are Predictive Biomarkers of Response to Imatinib Mesylate in Metastatic GIST Patients." Oncoimmunology 2016.
MLA CitationRusakiewicz, Sylvie, et al. "NKp30 Isoforms and NKp30 Ligands Are Predictive Biomarkers of Response to Imatinib Mesylate in Metastatic GIST Patients." Oncoimmunology 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.